STRYKER CORP Revenue
STRYKER CORP (SYK) reported Revenue of $6.59 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-07-31
- STRYKER CORP revenues for the quarter ending 2026-06-30 was $6.59B, a 9.42% increase year-over-year.
- STRYKER CORP revenues for the quarter ending 2026-03-31 was $6.02B, a 2.63% increase year-over-year.
- STRYKER CORP revenues for the quarter ending 2025-12-31 was $7.17B, a 11.42% increase year-over-year.
- STRYKER CORP revenues for the quarter ending 2025-09-30 was $6.06B, a 10.25% increase year-over-year.
- STRYKER CORP revenues for fiscal 2025 was $25.12B, a 11.16% increase from fiscal 2024.
- STRYKER CORP revenues for fiscal 2024 was $22.59B, a 10.23% increase from fiscal 2023.
- STRYKER CORP revenues for fiscal 2023 was $20.50B, a 11.11% increase from fiscal 2022.
- STRYKER CORP revenues for fiscal 2022 was $18.45B, a 7.84% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.59B 10-Q · filed 2026-07-31 | $12.61B 10-Q · filed 2026-07-31 | $19.78B derived: sum of 3 quarters · filed 2026-07-31 | $25.84B derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $6.02B 10-Q · filed 2026-05-11 | $13.19B derived: sum of 2 quarters · filed 2026-05-11 | $19.25B derived: sum of 3 quarters · filed 2026-05-11 | $25.27B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $7.17B 10-K · filed 2026-02-11 | $13.23B derived: sum of 2 quarters · filed 2026-02-11 | $19.25B derived: sum of 3 quarters · filed 2026-07-31 | $25.12B 10-K · filed 2026-02-11 |
| 2025-09-30 | $6.06B 10-K · filed 2026-02-11 | $12.08B derived: sum of 2 quarters · filed 2026-07-31 | $17.95B 10-Q · filed 2025-10-31 | $24.38B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $6.02B 10-Q · filed 2026-07-31 | $11.89B 10-Q · filed 2026-07-31 | $18.32B derived: sum of 3 quarters · filed 2026-07-31 | $23.82B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $5.87B 10-Q · filed 2026-05-11 | $12.30B derived: sum of 2 quarters · filed 2026-05-11 | $17.80B derived: sum of 3 quarters · filed 2026-05-11 | $23.22B derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $6.44B 10-K · filed 2026-02-11 | $11.93B derived: sum of 2 quarters · filed 2026-02-11 | $17.35B derived: sum of 3 quarters · filed 2026-02-11 | $22.59B 10-K · filed 2026-02-11 |
| 2024-09-30 | $5.49B 10-K · filed 2026-02-11 | $10.92B derived: sum of 2 quarters · filed 2026-02-11 | $16.16B 10-Q · filed 2025-10-31 | $21.97B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $5.42B 10-K · filed 2026-02-11 | $10.66B 10-Q · filed 2025-08-01 | $16.48B derived: sum of 3 quarters · filed 2026-02-11 | $21.39B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $5.24B 10-K · filed 2026-02-11 | $11.06B derived: sum of 2 quarters · filed 2026-02-11 | $15.97B derived: sum of 3 quarters · filed 2026-02-11 | $20.96B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $5.82B 10-K · filed 2025-02-12 | $10.72B derived: sum of 2 quarters · filed 2025-02-12 | $15.72B derived: sum of 3 quarters · filed 2025-02-12 | $20.50B 10-K · filed 2026-02-11 |
| 2023-09-30 | $4.91B 10-K · filed 2025-02-12 | $9.90B derived: sum of 2 quarters · filed 2025-02-12 | $14.68B 10-Q · filed 2024-10-30 | $19.89B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $5.00B 10-K · filed 2025-02-12 | $9.77B 10-Q · filed 2024-07-31 | $14.98B derived: sum of 3 quarters · filed 2025-02-12 | $19.45B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $4.78B 10-K · filed 2025-02-12 | $9.98B derived: sum of 2 quarters · filed 2025-02-12 | $14.46B derived: sum of 3 quarters · filed 2025-02-12 | $18.95B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $5.20B 10-K · filed 2024-02-14 | $9.68B derived: sum of 2 quarters · filed 2024-02-14 | $14.17B derived: sum of 3 quarters · filed 2024-02-14 | $18.45B 10-K · filed 2025-02-12 |
| 2022-09-30 | $4.48B 10-K · filed 2024-02-14 | $8.97B derived: sum of 2 quarters · filed 2024-02-14 | $13.25B 10-Q · filed 2023-11-03 | $17.95B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $4.49B 10-K · filed 2024-02-14 | $8.77B 10-Q · filed 2023-08-04 | $13.47B derived: sum of 3 quarters · filed 2024-02-14 | $17.63B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $4.28B 10-K · filed 2024-02-14 | $8.98B derived: sum of 2 quarters · filed 2024-02-14 | $13.14B derived: sum of 3 quarters · filed 2024-02-14 | $17.43B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $4.70B 10-K · filed 2023-02-10 | $8.86B derived: sum of 2 quarters · filed 2023-02-10 | $13.15B derived: sum of 3 quarters · filed 2023-02-10 | $17.11B 10-K · filed 2024-02-14 |
| 2021-09-30 | $4.16B 10-K · filed 2023-02-10 | $8.45B derived: sum of 2 quarters · filed 2023-02-10 | $12.41B 10-Q · filed 2022-11-01 | $16.67B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $4.29B 10-K · filed 2023-02-10 | $8.25B 10-Q · filed 2022-07-27 | $12.51B derived: sum of 3 quarters · filed 2023-02-10 | $16.25B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $3.95B 10-K · filed 2023-02-10 | $8.21B derived: sum of 2 quarters · filed 2023-02-10 | $11.95B derived: sum of 3 quarters · filed 2023-02-10 | $14.72B derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $4.26B 10-K · filed 2022-02-11 | $8.00B derived: sum of 2 quarters · filed 2022-02-11 | $10.76B derived: sum of 3 quarters · filed 2022-02-11 | $14.35B 10-K · filed 2023-02-10 |
| 2020-09-30 | $3.74B 10-K · filed 2022-02-11 | $6.50B derived: sum of 2 quarters · filed 2022-02-11 | $10.09B 10-Q · filed 2021-10-29 | $14.22B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $2.76B 10-K · filed 2022-02-11 | $6.35B 10-Q · filed 2021-07-28 | $10.48B derived: sum of 3 quarters · filed 2022-02-11 | $14.07B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $3.59B 10-K · filed 2022-02-11 | $7.72B derived: sum of 2 quarters · filed 2022-02-11 | $11.31B derived: sum of 3 quarters · filed 2022-02-11 | $14.96B derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $4.13B 10-K · filed 2021-02-11 | $7.72B derived: sum of 2 quarters · filed 2021-02-11 | $11.37B derived: sum of 3 quarters · filed 2021-02-11 | $14.88B 10-K · filed 2022-02-11 |
| 2019-09-30 | $3.59B 10-K · filed 2021-02-11 | $7.24B derived: sum of 2 quarters · filed 2021-02-11 | $10.75B 10-Q · filed 2020-10-30 | $14.55B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $3.65B 10-K · filed 2021-02-11 | $7.17B 10-Q · filed 2020-07-31 | $10.96B derived: sum of 3 quarters · filed 2021-02-11 | $14.20B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $3.52B 10-K · filed 2021-02-11 | $7.31B derived: sum of 2 quarters · filed 2021-02-11 | $10.55B derived: sum of 3 quarters · filed 2021-02-11 | $13.88B derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $3.80B 10-K · filed 2020-02-06 | $7.04B derived: sum of 2 quarters · filed 2020-02-06 | $10.36B derived: sum of 3 quarters · filed 2020-02-06 | $13.60B 10-K · filed 2021-02-11 |
| 2018-09-30 | $3.24B 10-K · filed 2020-02-06 | $6.56B derived: sum of 2 quarters · filed 2020-02-06 | $9.80B 10-Q · filed 2019-10-30 | $13.28B derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $3.32B 10-K · filed 2020-02-06 | $6.56B 10-Q · filed 2019-07-26 | $10.03B derived: sum of 3 quarters · filed 2020-02-06 | $13.04B derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $3.24B 10-K · filed 2020-02-06 | $6.71B derived: sum of 2 quarters · filed 2020-02-06 | $9.72B derived: sum of 3 quarters · filed 2020-02-06 | $12.73B derived: sum of 4 quarters · filed 2020-02-06 |
| 2017-12-31 | $3.47B 10-K · filed 2019-02-07 | $6.48B derived: sum of 2 quarters · filed 2019-02-07 | $9.49B derived: sum of 3 quarters · filed 2019-02-07 | $12.44B 10-K · filed 2020-02-06 |
| 2017-09-30 | $3.01B 10-K · filed 2019-02-07 | $6.02B derived: sum of 2 quarters · filed 2019-02-07 | $8.97B 10-Q · filed 2018-10-26 | |
| 2017-06-30 | $3.01B 10-K · filed 2019-02-07 | $5.97B derived: sum of 2 quarters · filed 2019-02-07 | ||
| 2017-03-31 | $2.96B 10-K · filed 2019-02-07 | |||
| 2016-12-31 | $11.32B 10-K · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |